Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles van Cutsem

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Plos Medicine|July 11, 2008
Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland comparedOlivia Keiser, Catherine Orrell, Matthias Egger, et al.
Plos One|November 19, 2010
Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South AfricaHelen S Cox, Cheryl McDermid, Virginia Azevedo, et al.
Journal of the International AIDS Society|July 9, 2013
Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South AfricaGabriela E M Patten, Lynne Wilkinson, Karien Conradie, et al.
Plos One|September 7, 2017
Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: A feasibility study in rural LesothoFernanda Rick, Aline Aurore Niyibizi, Amir Shroufi, et al.
The Lancet. HIV|May 31, 2020
Framework for the implementation of advanced HIV disease diagnostics in sub-Saharan Africa: programmatic perspectivesZibusiso Ndlovu, Rosie Burton, Rosanna Stewart, et al.
Southern African Journal of HIV Medicine|March 24, 2018
HIV testing and antiretroviral therapy initiation at birth: Views from a primary care setting in KhayelitshaAurélie Nelson, Jean Maritz, Janet Giddy, et al.
Antiviral Therapy|August 24, 2007
Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohortAndrew Boulle, Catherine Orrel, Richard Kaplan, et al.
BMC Public Health|March 4, 2018
Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional surveyHelena Huerga, Gilles Van Cutsem, Jihane Ben Farhat, et al.
Open Forum Infectious Diseases|June 3, 2015
Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South AfricaHelen S Cox, Johnny F Daniels, Odelia Muller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 26, 2010
Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaborationMary-Ann Davies, Harry Moultrie, Brian Eley, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Plos Medicine|July 11, 2008
Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland comparedOlivia Keiser, Catherine Orrell, Matthias Egger, et al.
Plos One|November 19, 2010
Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South AfricaHelen S Cox, Cheryl McDermid, Virginia Azevedo, et al.
Journal of the International AIDS Society|July 9, 2013
Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South AfricaGabriela E M Patten, Lynne Wilkinson, Karien Conradie, et al.
Plos One|September 7, 2017
Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: A feasibility study in rural LesothoFernanda Rick, Aline Aurore Niyibizi, Amir Shroufi, et al.
The Lancet. HIV|May 31, 2020
Framework for the implementation of advanced HIV disease diagnostics in sub-Saharan Africa: programmatic perspectivesZibusiso Ndlovu, Rosie Burton, Rosanna Stewart, et al.
Southern African Journal of HIV Medicine|March 24, 2018
HIV testing and antiretroviral therapy initiation at birth: Views from a primary care setting in KhayelitshaAurélie Nelson, Jean Maritz, Janet Giddy, et al.
Antiviral Therapy|August 24, 2007
Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohortAndrew Boulle, Catherine Orrel, Richard Kaplan, et al.
BMC Public Health|March 4, 2018
Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional surveyHelena Huerga, Gilles Van Cutsem, Jihane Ben Farhat, et al.
Open Forum Infectious Diseases|June 3, 2015
Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South AfricaHelen S Cox, Johnny F Daniels, Odelia Muller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 26, 2010
Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaborationMary-Ann Davies, Harry Moultrie, Brian Eley, et al.
Pageof 9